S75: How Should We Oversee AI in Medicine to Ensure Safety and Facilitate Innovation?
Presentation Type: Panel
How Should We Oversee AI in Medicine To Ensure Safety and Facilitate Innovation?
Presentation Time: 02:00 PM - 03:15 PM
Abstract Keywords: Artificial Intelligence, Governance, Legal, Ethical, Social and Regulatory Issues, Patient Safety, Informatics Implementation, Healthcare Quality, Clinical Decision Support
Primary Track: Policy
Programmatic Theme: Clinical Informatics
The use of artificial intelligence (AI) in clinical care is rapidly accelerating. While AI tools show promise for improving patient care and streamlining clinical workflows, understanding of the requirements for overseeing the implementation and ensuring safety of such tools is lacking. Traditional medical device oversight frameworks are inadequate for many AI tools, because patient populations, clinical practice, documentation, and information systems vary considerably across hospitals and clinics and vary over time. In this panel, we will bring together a diverse set of experts to describe the gaps in the current oversight of clinical AI systems and discuss opportunities to solidify emerging policy and practice efforts for optimal oversight.
Moderator: GARY WEISSMAN,
MD, MSHP University of Pennsylvania
Speakers: Rezwan
Ahmed,
PhD Roche
Daniel
Herman,
MD, PhD University of Pennsylvania
Nicoleta
Economou-Zavlanos,
Ph.D. Duke University
Authors: Daniel Herman, MD, PhD - University of Pennsylvania;GARY WEISSMAN, MD, MSHP - University of Pennsylvania;
GARY WEISSMAN,
MD, MSHP - University of Pennsylvania
Rezwan
Ahmed,
PhD - Roche
Daniel
Herman,
MD, PhD - University of Pennsylvania
Nicoleta
Economou-Zavlanos,
Ph.D. - Duke University
S75: How Should We Oversee AI in Medicine to Ensure Safety and Facilitate Innovation?